Home › Funds › Nan Fung Group Holdings Ltd › OCS

Nan Fung Group Holdings Ltd position in OCS

OCULIS HOLDING AG · Health Care

Nan Fung Group Holdings Ltd reported holding 300,565 shares of OCS (OCULIS HOLDING AG) in its Q3 2026 13F filing — a position valued at US$2.8M, representing 1.90% of its reported portfolio and ranking #16 among its reported holdings. Nan Fung Group Holdings Ltd has disclosed OCS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)300.56K sh
Reported value held$2.81M
Portfolio Weight1.90%
First reportedQ3 2023
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Nan Fung Group Holdings Ltd's OCS position evolved

Nan Fung Group Holdings Ltd first disclosed a stake in OCS in Q3 2023 at 606,684 shares (US$6.7M). The position peaked in Q4 2025 at 514,702 shares, worth US$10.3M. Across 13 filings, Nan Fung Group Holdings Ltd increased the stake 1 time(s), trimmed it 4 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 300,565 shares valued at US$2.8M. Notable position changes include a 32% trim in Q1 2026 (shares fell 48% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 606.68K $6.67M New
Q4 2023 518.93K $5.83M Reduce
Q1 2024 436.38K $5.26M Reduce
Q2 2024 436.38K $5.21M Hold
Q3 2024 436.38K $5.35M Hold
Q4 2024 436.38K $7.42M Hold
Q1 2025 514.70K $9.79M Add
Q2 2025 514.70K $9.99M Hold
Q3 2025 514.70K $9.05M Hold
Q4 2025 514.70K $10.28M Hold
Q1 2026 350.75K $9.33M Reduce
Q2 2026 300.56K $4.17M Reduce
Q3 2026 300.56K $2.81M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About OCS and 13F data

OCS (OCULIS HOLDING AG) is a Health Care company. 66 other funds we track also report a position in OCS — the largest reported positions include EQT Fund Management S.a r.l. (US$64.9M), Gildi - lifeyrissjodur (US$64.3M), Pivotal bioVenture Partners Investment Advisor LLC (US$15.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding OCS

All OCS fund holders →

FAQ

How long has Nan Fung Group Holdings Ltd held OCS?

Nan Fung Group Holdings Ltd has disclosed OCS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Nan Fung Group Holdings Ltd's current position in OCS?

As of Q3 2026, Nan Fung Group Holdings Ltd holds 300.56K shares of OCS (OCULIS HOLDING AG), valued at $2.81M, representing 1.90% of its reported portfolio and ranking #16.

Has Nan Fung Group Holdings Ltd been buying or selling OCS?

In the latest 13F filing (Q3 2026), Nan Fung Group Holdings Ltd held unchanged its position in OCS. The position peaked in Q4 2025 at 514.70K shares.

Which other funds hold OCS?

Other major institutional holders of OCS include EQT Fund Management S.a r.l., Gildi - lifeyrissjodur, Pivotal bioVenture Partners Investment Advisor LLC, among 66 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.